被调出港股通名单，科济药业盘中跌超13%
3月10日，科济药业股价开盘后大跌。截至发稿前，科济药业盘中跌超13%，股价报13.84港元/股。3月7日，上交所发布《关于沪港通下港股通标的调整的通知》，因恒生综合大型股指数、中型股指数、小型股指数实施成份股调整，沪港通下港股通标的名单发生调整，并自下一港股通交易日（即2025年3月10日）起生效。其中，科济药业、康宁杰瑞制药、来凯医药等多家Biotech均在调出名单内。（时代财经杜苏敏）
（文章来源：时代财经）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10